Prakiraan rega marang bathi: metaviatx.com (MTVA)
MetaVia Inc (MTVA) is currently testing its neurodisorder treatments while maintaining strict control over R&D expenditures. The company's forward P/E ratio on this GURU.Markets chart confirms this, where the value 0.00 aligns with the current metric. The business model relies on full production outsourcing, while its environmental strategy is implemented through research bioethics and energy-efficient laboratory processes.
Rincian analitis lan laporan data perusahaan MetaVia, Inc. (MTVA)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal MetaVia Inc|MTVA - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal MetaVia Inc|MTVA - Gunggung utang perusahaan|Utang marang nilai buku MetaVia, Inc.|MTVA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MetaVia|Likuiditas cepet metaviatx.com
- statistik bathi lan rasio pasar:
MTVA - Bathi perusahaan|Proyeksi bathi mangsa ngarep MetaVia Inc|MTVA - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep MetaVia Inc|MTVA - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MetaVia, Inc.|MTVA - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan MetaVia|MTVA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan metaviatx.com|MTVA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MetaVia Inc
Analisis komprehensif perusahaan:MetaVia MTVA
The forward P/E determines the ratio of MetaVia Inc. (MTVA) current market capitalization to expected annual earnings, measuring market optimism regarding profit growth rates. By analyzing the company's valuation via the forward P/E, an investor determines the asset's margin of safety, where low values confirm an undervaluation of the potential for precision medicine and innovative therapies for complex metabolic disorders within the business structure.
Pesaing langsung
Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Regencell - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep AXSM (Axsome Corp)|ACADIA Pharmaceuticals - Pangali Forward P/E|XENE - Pangali Forward P/E|VKTX (Viking Therapeutics, Inc.) - Prakiraan rega marang bathi|SUPN (Supernus Pharmaceuticals, Inc.) - Rega marang bathi mangsa ngarep|CPRX (Catalyst Pharmaceuticals Inc) - Pangali Forward P/E|Denali Corp (DNLI) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E HRMY|Pangali Forward P/E biohavenpharma.com (BHVN)|Amylyx Pharmaceuticals, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TRVI|Praxis Medicines - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Anavex Life Sciences Corp AVXL|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PRTA|ALEC (Alector Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Annexon Biosciences (ANNX)|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|Prakiraan rega marang bathi Neurogene Therapeutics NGNE|AC Immune - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep VYGR (voyagertherapeutics.com)|NMRA: Prakiraan rega marang bathi|SCLX: Rega marang bathi mangsa ngarep|TVGN: Pangali Forward P/E|Alpha Cognition Inc. (ACOG) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Cognition Therapeutics|Rasio rega marang bathi mangsa ngarep IKT (inhibikase.com)|Pangali Forward P/E SAVA|ASRT - Rasio prakiraan rega marang bathi|Coya Therapeutics - Prakiraan rega marang bathi|Pangali Forward P/E VistaGen Therapeutics, Inc. VTGN|OVID - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi ABOS (acumenpharm.com)|CervoMed (CRVO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Alterity Therapeutics Limited (ATHE)|Rega marang bathi mangsa ngarep Clene Inc|Prakiraan rega marang bathi PepGen Corp (PEPG)|Pangali Forward P/E JUNS|RLMD - Rasio prakiraan rega marang bathi|Annovis Bio - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep GRCE (Grace Therapeutics Inc)|Firefly Neuroscience Inc - Pangali Forward P/E|KLTO - Pangali Forward P/E|NRSN (neurosense-tx.com) - Prakiraan rega marang bathi|RVPH (revivapharma.com) - Rega marang bathi mangsa ngarep|NRXS (NeurAxis) - Pangali Forward P/E|Helius Medical Technologies Inc. (HSDT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E PASG|Pangali Forward P/E bionomics.com.au (NEUP)|Minerva Neurosciences - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ATHA|Addex Therapeutics Ltd - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Alzamend Neuro, Inc. ALZN|cyclerion.com (CYCN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PTIX|KTTA (Pasithea Therapeutics Corp) - Pangali Forward P/E|Prakiraan rega marang bathi Cortigent Medical (CRGT)|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|Prakiraan rega marang bathi Brainstorm Cell Therapeutics Inc. BCLI|Cara Therapeutics, Inc - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep CHRO (Chromocell)|ELYM: Prakiraan rega marang bathi|ITCI: Rega marang bathi mangsa ngarep|LBPH: Pangali Forward P/E|Marinus Pharmaceuticals Inc (MRNS) - Pangali Forward P/E|Rega marang bathi mangsa ngarep NKGen|Rasio rega marang bathi mangsa ngarep NRBO (NeuroBo Pharma)|Pangali Forward P/E SAGE|SNPX - Rasio prakiraan rega marang bathi|Trevena - Prakiraan rega marang bathi|Pangali Forward P/E Vigil Neuroscience Inc. VIGL|WENA - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Corp)
